Archives zymogenetics

by in
Entry Author Date Location
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash 10/18/10 Seattle
Seattle Genetics Nails 2nd Trial, Bristol Clinches Zymo Buyout, Halosource Goes Public, & More Seattle-Area Life Sciences News 10/14/10 Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics 10/08/10 Seattle
Embryonic Stem Cell Research Foe, Tracy Deisher, Seeks to Market Pro-Life Vaccines 10/01/10 Seattle
Our Top 20 Stories of the Third Quarter: What’s Making Waves in the NW’s Tech and Biotech Sectors 09/30/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
ZymoGenetics Will Be Missed. How Seattle Biotech Can Recover and Thrive 09/21/10 Seattle
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive 09/14/10 Seattle
What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots? 09/13/10 Seattle
ZymoGenetics Reaches the End, Stratos Genomics Nabs $4M, Children’s New Ventilator, & More Seattle-Area Life Sciences News 09/09/10 Seattle
ZymoGenetics Reaches End of Road in Seattle, Faces Uncertain Future, Potential Job Cuts 09/07/10 Seattle
ZymoGenetics, Seattle Biotech Pioneer, Acquired by Bristol-Myers for $885M 09/07/10 Seattle
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas 08/05/10 Seattle
Xconomy Seattle’s Top 20 Stories of the Quarter: The Quest for the Land Speed Record, Dendreon Makes History, & Geoff Entress Up Close 07/02/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Wings Replaces Kraemer With Cramer, Adding Elder Statesman of Northwest Life Sciences 06/10/10 Seattle
ZymoGenetics Melanoma Drug Passes Small Study, Gets Overshadowed by Bristol-Myers 06/05/10 Seattle
Generating a Human Return on Investment: Three Young Scientists Pursue Dreams 05/25/10 Seattle
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs 03/19/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Page 2 of 6 « previous page · next page »